Immune cells from tumors turned into cancer fighters in early trial
NCT ID NCT04967833
First seen Nov 01, 2025 · Last updated May 01, 2026 · Updated 20 times
Summary
This early-stage study tests a personalized cell therapy for people with advanced solid tumors that have not responded to standard treatments. Doctors take immune cells from a patient's own tumor, grow them in large numbers, and give them back through an IV. The goal is to see if this approach is safe and can shrink tumors. The study involves 20 participants and includes chemotherapy beforehand to prepare the body.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED SOLID TUMORS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tongren Hospital Shanghai Jiao Tong University School Of Medicine.
RECRUITINGShanghai, China
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.